GEAR unites industry leaders in gene editing, RNA modalities, delivery platforms, and biopharmaceutical manufacturing to accelerate translation from breakthrough science to commercial impact. Attendees gain strategic insights into platform scalability, regulatory pathways, manufacturing challenges, and emerging therapeutic opportunities — all while forging partnerships that drive competitive advantage in the rapidly evolving genetic medicine market.


Abstract Submissions Due: May 26, 2026
Submit here: https://aiche.confex.com/aiche/gear26/cfp.cgi

Learn more: https://www.aiche.org/sbe/conferences/gene-editing-and-rna-technologies-gear/2026?utm_source=WikiCF&utm_medium=Ad&utm_campaign=GEAR2026

SESSION TOPICS
•Gene Editing
•Targeted Delivery
•RNA Technologies
•Manufacturing
•Applications of AI/ML in RNA Therapeutics

Keynote Speakers
Georges Belfort, Rensselaer Polytechnic Institute
George Church, Harvard Medical School and MIT
Amy S. Espeseth, Sail Biomedicines
David Liu, Broad Institute
Laura Sepp-Lorenzino, GNMmeds LLC

Conference Chairs
Lee Klein, Merck & Co.
Giulia Schiroli, Tessera Therapeutics
Joanna Sztuba-Solinska, Merck & Co.
Weixin Tang, University of Chicago

Organizing Committee
Georges Belfort, Rensselaer Polytechnic Institute
Andrew Berglund, University at Albany
Rodney Combs, Pfizer, Inc.
Jonathan Hoggatt, Moderna
Gregg Nyberg, Landmark Bio
Jose Russo, Pfizer
Aleš Štrancar, BIA Separations
Andrew Zydney, The Pennsylvania State University

Conference Organized by the Society for Biological Engineering

About SBE
Established in 2004, the Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE’s mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. Learn more about SBE at https://www.aiche.org/sbe